K
Kereon Partners
Kereon Partners is a Spanish venture capital firm founded in 2011, headquartered in Bilbao with additional offices in Madrid and Barcelona. It backs projects from seed through growth stage across sectors like healthcare/life sciences, food & agriculture, industrial, clean energy and technology, typically investing in the €1-5M range per project with a hands-on, business-angel-style involvement. Its portfolio of roughly 20 companies includes Atlas Molecular Pharma, OWL Metabolomics, QualityFry and Next Electric Motors.
SectorsHealthcare & Life Sciences, Biotech/Pharma, Food & Agriculture, Industrial/Manufacturing, Clean Energy & Mobility, Technology
VC MapSeries A
Team
L
Lorenzo Mendieta Sola
PARTNER. CONSEJERO DELEGADO.
J
Joaquín Sanz Berrioategortua
PARTNER. DIRECTOR DE INVERSIONES
M
Manu Arteche Fdez-Miranda
PARTNER. DIRECTOR DE INVERSIONES
M
Mario Onzain Ornilla
PARTNER. DIRECTOR DE INVERSIONES
J
Juan Arriola Zalbide
PARTNER. DIRECTOR DE INVERSIONES
Portfolio companies 9
Open 6 as list → On map →
NNEXT Electric Motors
led Seed (estimated), 2023
DDatadope
led Seed (estimated), 2022
AAtlas Molecular Pharma
entered at Series A (estimated), 2022
PPersei Vivarium
entered at Seed, 2018
M
Maxcolchon
led a round, 2016
BBiokemik
entered at Seed, 2015
Exited or sunsetted (3)
MMétodo Supertics
per company site
OOWL Metabolomics
per company site
T
Transplant Biomedicals
per company site
Funding rounds 7
Open as list →| Date | Company | Round | Amount | Lead |
|---|---|---|---|---|
| 2023-05-30 | NEXT Electric Motors | Seed (estimated) | €1M | Kereon Partners |
| 2022-05-12 | Datadope | Seed (estimated) | €1M | Kereon Partners |
| 2022-02-01 | Atlas Molecular Pharma | Series A (estimated) | €3M |
Inveready, CDTI, Ezten FCR (Grupo SPRI)
+3 more
|
| 2020-10-02 | NEXT Electric Motors | Seed (estimated) | €500K | Kereon Partners |
| 2018-04 | Persei Vivarium | Seed | approximately $1.2M |
Lead not disclosed
+2 more
|
| 2016-11-15 | Maxcolchon | No stage disclosed | — | Kereon Partners |
| 2015-05 | Biokemik | Seed | — |
Lead not disclosed
+2 more
|
News
No coverage on record yet.